Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.95 USD | +1.22% | +0.20% | -29.08% |
Apr. 02 | Goldman Sachs Initiates Olema Pharmaceuticals at Buy With $24 Price Target | MT |
Mar. 18 | Olema Pharmaceuticals, Inc.(NasdaqGS:OLMA) added to S&P Biotechnology Select Industry Index | CI |
Business Summary
Number of employees: 74
Managers
Managers | Title | Age | Since |
---|---|---|---|
Peter Kushner
FOU | Founder | 86 | 06-08-06 |
Sean Bohen
CEO | Chief Executive Officer | 58 | 20-08-31 |
Cyrus Harmon
FOU | Founder | 54 | 06-08-06 |
Shane Kovacs
DFI | Director of Finance/CFO | 50 | 20-05-31 |
Kristin Lanzi
CTO | Chief Tech/Sci/R&D Officer | - | - |
Naseem Zojwalla
CTO | Chief Tech/Sci/R&D Officer | 51 | 22-01-30 |
Sasha Austin
AUD | Comptroller/Controller/Auditor | - | 20-12-31 |
General Counsel | - | 22-06-30 | |
Julie Dexter
HRO | Human Resources Officer | - | - |
David Myles
PRN | Corporate Officer/Principal | 62 | 08-03-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Ian Clark
CHM | Chairman | 62 | 20-07-31 |
J. Garland
BRD | Director/Board Member | 55 | 23-10-15 |
Andy Rappaport
BRD | Director/Board Member | 66 | 12-12-31 |
Cyrus Harmon
FOU | Founder | 54 | 06-08-06 |
Cynthia Butitta
BRD | Director/Board Member | 70 | 20-07-31 |
Sean Bohen
CEO | Chief Executive Officer | 58 | 20-08-31 |
Sandra Horning
BRD | Director/Board Member | 75 | 20-11-12 |
Director/Board Member | 35 | 18-06-30 | |
Yi Larson
BRD | Director/Board Member | 44 | 21-04-05 |
Graham Walmsley
BRD | Director/Board Member | 37 | 20-02-29 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 56,019,075 | 53,713,335 ( 95.88 %) | 104,334 ( 0.1862 %) | 95.88 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.08% | 557M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- OLMA Stock
- Company Olema Pharmaceuticals, Inc.